Breath by Breath (B3)

The 9.8million people lost their lives due to cancer in 2018. Among that Lung cancer was the most ferocious and brutal type of cancer. According to WHO cancer death is not due to poor medication, indeed due to lack of diagnosis technology. Current screening techniques are expensive, time-consuming and blood-based. They need to upgrade and become more feasible for all people. The challenge of poor diagnosis has been found mostly in developing and underdeveloped countries, who can not afford expensive screening devices like PET, MRI, etc. This is high time to introduce a compact solution to this issue.

There are many ways to detect cancer presence. Here we are delivering An advanced solution for the detection of lung cancer at the highest precision, Rapid and non-blood based. We are developing a breath analyzer that used a volatile organic compound as a biomarker for lung cancer. It would have the highest sensing time, best selectivity and a point on care solution-based device. The technology behind is used on MWNT with a define configuration to absorb one of the highly unregulated VOCs. Our solution carriers high hope and possibilities to cover huge markets and customers around the globe.